Recently, the 21st National Academic Meeting of Chinese Society of Otolaryngology-Head and Neck Surgery was held as scheduled in Hefei, Anhui Province, China.
Grand Pharma is deeply committed to the field of Pentacenter, in order to promote the flourishing development of Pentacenter, two member companies of our group, Xi’an Beilin Pharmaceutical Co., Ltd. and Hubei Grand EBE Pharmaceutical Company Limited were invited to participate in this conference, and actively support the high-quality development of otorhinolaryngology, head and neck surgery in China.
During the conference, the company brought its enterprise laryngology proprietary Chinese medicine and rhinology chemical products to the conference booth. Our products are a combination of traditional Chinese and western medicine, anchored in otorhinolaryngology, head and neck surgery, voice protection, and synergistic development in multiple fields.
During the meeting, the booth conducted clinical Q&A and product satisfaction surveys with the attending experts by holding activities such as code-sweeping sign-in and questionnaire surveys. Through face-to-face communication with experts, we provide new product information, maintain new user needs, expand new product direction, and actively promote the steady development of the company in the field of otolaryngology. The venue was crowded, experts were enthusiastic and conveyed highly satisfied and positive feedback on the company’s products.
